Generics Cos. Infringed Lysteda IP, Fed. Circ. Told
Ferring Pharmaceuticals Inc. asked the Federal Circuit on Tuesday to affirm a finding of infringement against Watson Pharmaceuticals Inc. in a dispute over heavy menstrual bleeding medication Lysteda and to reverse...To view the full article, register now.
Already a subscriber? Click here to view full article